Neurology Central

Glioblastoma aggression and spread predicted by new assay

Researchers from John Hopkins Medicine (MD, USA) have developed an assay that has the potential to determine the aggression and rate of spread of glioblastoma tumors. This information could enable clinicians to make more informed treatment choices and provide patients with a more accurate prognosis than is currently possible.

Alfredo Quinones-Hinojosa, John Hopkins University School of Medicine (MD, USA), explained: “After I remove a brain tumor from a patient, the patient always asks me, ‘Doc, how long do I have?’ I don’t have a reliable way to answer them. But we have taken a step to creating a possible way to provide useful updates, inform treatment choices and perhaps develop new treatments faster.”

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.